Coronavirus: Commission offers financing to innovative vaccines company CureVac

Mar 24, 2020

The Commission offered up to €80 million of financial support to CureVac, a higly innovative vaccine developer from Tübingen, Germany, to scale up development and production of a vaccine against the Coronavirus in Europe. Read more here

Source: EU Science and Innovation


Other news